Reinfection by Opisthorchis viverrini after treatment with praziquantel

Asian Pacific Journal of Cancer Prevention

Volumn 17, Issue 2, 2016, Pages 857-862

  Saengsawang, Phubet ^a   Promthet, Supannee ^b   Bradshaw, Peter ^b  

^a Yasothon Province   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Northeastern Thailand; Opisthorchis viverrini; Reinfection

Indexed keywords

ANTHELMINTIC AGENT; PRAZIQUANTEL;

ADULT; AGED; ANIMAL; BILE DUCT NEOPLASMS; CHEMICALLY INDUCED; CHOLANGIOCARCINOMA; DRUG EFFECTS; FEMALE; FOLLOW UP; HUMAN; INTRAHEPATIC BILE DUCT; MALE; MIDDLE AGED; OPISTHORCHIASIS; OPISTHORCHIS; PARASITOLOGY; PATHOGENICITY; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; THAILAND; YOUNG ADULT;

ADULT; AGED; ANIMALS; ANTHELMINTICS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OPISTHORCHIASIS; OPISTHORCHIS; PRAZIQUANTEL; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; THAILAND; YOUNG ADULT;

EID: 84960393845     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2016.17.2.857     Document Type: Article

References (33)

1. Aunpromma S, Tangkawattana P, Papirom P, et al (2012). High prevalence of Opisthorchis viverrini infection in reservoir hosts in four districts of Khon Kaen Province, an opisthorchiasis endemic area of Thailand. Parasitol Int, 61, 60-4
2. Boonmars T, Srirach P, Kaewsamut B, et al (2008). Apoptosisrelated gene expression in hamster opisthorchiasis post praziquantel treatment. Parasitol Res, 102, 447-55
3. Chernrungroj G (2000). Risk factors for cholangiocarcinoma: a case-control study. Yale University, New Haven, Connecticut.
4. Grundy-Warr C, Andrews RH, Sithithaworn P, et al (2012). Raw attitudes, wetland cultures, life-styles: Socio-cultural dynamics relating to Opisthorchis viverrini in the Mekong basin. Parasitol Int, 61, 65-70.
5. IARC. Schistosomes, liver flukes and Helicobacterpylori (1994). IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monogr Eval Carcinog Risks Hum, 61, 1-241.
6. IARC. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2012). Biological agents. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum, 100, 1-441.
7. Kamsa-ard S, Laopaiboon M, Bhudhisawasdi V (2013). Association between Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Systematic Review and Meta-Analysis. Asian Pacific J Cancer Prev, 14, 7011-6.
8. Kamsa-ard S, Luvira V, Pugkhem A, et al (2015). Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study. BMC Cancer, 15, 776.
9. Khuhaprema T, Srivatanakul P, Attasara P, et al (2010). Cancer in Thailand 2001-2003. vol.V. Bangkok Medical Publisher, Bangkok.
10. Lovis L, Mak TK, Phongluxa K, et al (2009). PCR diagnosis of Opisthorchis viverrini and Haplorchis taichui infections in a Lao community in an area of endemicity and comparison of diagnostic methods for parasitological field surveys. J Clin Microbiol, 47, 1517-23.
11. Lovis L, Mak TK, Phongluxa K, et al. (2012). Efficacy of praziquantel against Schistosoma mekongi and Opisthorchis viverrini: a randomized, single-blinded dose-comparison trial. PLoS Negl Trop Dis, 6, 1726.
12. Miwa M, Honjo S, You G, et al (2014). Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand. World J Gastrointest Pathophysiol, 15, 570-8.
13. Pinlaor S, Ma N, Hiraku Y, et al (2004). Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7, 8-dihydro-2'-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis, 25, 1535-52.
14. Poomphakwaen K, Promthet S, Kamsa-ard S, et al (2009). Risk factors for cholangiocarcinoma in Khon Kaen, Thailand: a nested case-control study. Asian Pac J Cancer Prev, 10, 251-7.
15. Prasongwatana J, Laummaaunwai P, Boonmars P, Pinloar S (2013). Viable metacercariae of Opisthorchis viverrini in northeastern Thai cyprinid dishes-as part of a rational program for control of O. viverrini-associated cholangiocarcinoma. Parasitol Res, 112, 1323-7.
16. Pungpak S, Chalermrut K, Harinasuta T, et al (1994) Opisthorchis viverrini infection in Thailand: symptoms and signs of infection-apopulation-based study. Trans R Soc Trop Med Hyg, 88, 561-4
17. Saengsawang P, Promthet S, Bradshaw P (2012). Prevalence of OV infection in Yasothon Province, Northeast Thailand. Asian Pac J Cancer Prev, 13, 3399-402.
18. Sayasone S, Utzinger J, Akkhavong K, Odermatt P (2015). Repeated stool sampling and use of multiple techniques enhance the sensitivity of helminth diagnosis: A crosssectional survey in southern Lao People's Democratic Republic. Acta Tropica, 141, 315-21.
19. Sithithaworn P, Tesana S, Pipitgool V, et al (1991). Relationship between faecal egg count and worm burden of Opisthorchis viverrini in human autopsy cases. Parasitol, 102, 277-81.
20. Sithithaworn P, Andrews RH, Nguyen VD, et al (2012). The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int, 61, 10-6.
21. Sithithaworn P, Yongvanit P, Duenngai K, Kiatsopit K, Pairojkul C (2014). Roles of liver fluke infection as risk factor for cholangiocarcinoma. J Hepatobiliary Pancreat Sci, 21, 301-8.
22. Songserm N, Promthet S, Sithithaworn P, et al (2012). Risk factors for cholangiocarcinoma in high-risk area of Thailand: role of lifestyle, diet and methylenetetrahydrofolate reductase polymorphisms. Cancer Epidemiol, 36, 89-94.
23. Sornmani S, Vivatanasesth P, Impand P, et al (1984). Infection and reinfection rates of opisthorchiasis in the water resource development area of Nam Pong project, Khon Kaen Province, northeast Thailand. Ann Trop Med Parasitol, 78, 649-56.
24. Sripa B, Kaewkes S, Sithithaworn P, et al (2007). Liver fluke induces cholangiocarcinoma. PLoS Med, 4, 201.
25. Sripa B, Pairojkul C (2008). Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol, 24, 349-56.
26. Sripa B, Bethony JM, Sithithaworn B, et al (2011). Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Tropica, 120, 158-68.
27. Sripa B, Tangkawattan T, Laha L, et al (2015). Toward integrated opisthorchiasis control in northeast Thailand: The Lawa project. Acta Tropica, 141, 361-7.
28. Sudsarn P, Boonmars T, Ruangjirachuporn W, et al (2015). Combination of praziquantel and aspirin minimizes liver pathology of hamster Opisthorchis viverrini infection associated cholangiocarcinoma. Pathol Oncol Res, 15, 9967.
29. Upatham ES, Viyanant V, Brockelman WY, et al (1988). Rate of re-infection by Opisthorchis viverrini in an endemic northeast Thai community after chemotherapy. Int J Parasitol, 18, 643-9.
30. Watanapa P, Watanapa W (2002). Liver fluke-associated cholangiocarcinoma. Br J Surg, 89, 962-70.
31. Wongpa N, Thaewnongiew K, Phathee K (2011). Liver fluke infection and control in the Northeast of Thailand through action research. Asian Pac J Cancer Prev, 12, 1367-70
32. Worasith C, Kamamia C, Yakovleva A, et al (2015). Advances in the diagnosis of human opisthorchiasis: development of opisthorchis viverrini antigen detection in Urine. PLoS Negl Trop Dis, 9, 4157.
33. World Health Organization (1991). Basic laboratory methods in medical parasitology. WHO, Geneva, 25-28.